HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


L'Oreal/EPA Partnership Could Expand Non-Animal Test Strategies

This article was originally published in The Rose Sheet

Executive Summary

L’Oreal and the U.S. EPA are collaborating to test the usefulness of the agency’s chemical-screening platform in predicting the toxicity of cosmetic substances – particularly vis-a-vis sensitive endpoints for which alternative tests currently do not exist – in advance of an EU ban on cosmetic products tested on animals.

You may also be interested in...

Questions Remain On Animal Testing Ban, Possible Loopholes

While it appears inevitable that the European Commission’s full ban on testing cosmetic ingredients on animals will proceed starting March 11 as dictated by the Cosmetics Directive, how the EC and member states will interpret and enforce the ban remains to be seen. Consulting firm Technology Sciences Group believes the regulation may be more flexible, and less onerous, than anticipated.

NTP Five-Year Plan Prioritizes Collaboration, Anticipates Tech Innovations

Interagency groups under the U.S. National Toxicology Program release their latest draft Five-Year Plan, which will push for adoption of new alternatives to animal tests and technologies to enhance methods.

NTP Touts 2010-2011 Achievements In Race To End Animal Testing

Interagency Groups under NIH’s National Toxicology Program contributed to the adoption of 14 new and updated test methods to refine, reduce and replace the use of animals, and continued making strides toward global harmonization, in 2010-2011. NICEATM and ICCVAM provide a progress report.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts